Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Adler

Showing results (141-150 of 203) with videos related to

Pageof 21
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2005
Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67)A I Adler, J C Levy, D R Matthews, et al.
Ophthalmology|November 11, 2009
Micronutrients and diabetic retinopathy a systematic reviewChee-Tin Christine Lee, Emma L Gayton, Joline W J Beulens, et al.
Diabetes Care|July 1, 1997
Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot StudyA I Adler, E J Boyko, J H Ahroni, et al.
The FEBS Journal|April 25, 2022
Dietary restriction and lifespan: adaptive reallocation or somatic sacrifice?Matthew D W Piper, Brooke Zanco, Carla M Sgrò, et al.
International Journal of Circumpolar Health|March 27, 1999
Glucose tolerance and insulin-resistance syndrome among St. Lawrence Island EskimosC D Schraer, S O Ebbesson, A I Adler, et al.
Diabetes Care|December 25, 2003
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66Richard J Stevens, Ruth L Coleman, Amanda I Adler, et al.
Diabetes Care|April 30, 2002
UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetesAmanda I Adler, Richard J Stevens, Andrew Neil, et al.
Kidney International|December 11, 2002
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)Amanda I Adler, Richard J Stevens, Sue E Manley, et al.
Eclinicalmedicine|January 7, 2025
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort studyRiccardo De Giorgi, Ivan Koychev, Amanda I Adler, et al.
Diabetologia|June 1, 2006
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)I M Stratton, C A Cull, A I Adler, et al.
Pageof 21

Showing results (141-150 of 203) with videos related to

Sort By:
Pageof 21
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2005
Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67)A I Adler, J C Levy, D R Matthews, et al.
Ophthalmology|November 11, 2009
Micronutrients and diabetic retinopathy a systematic reviewChee-Tin Christine Lee, Emma L Gayton, Joline W J Beulens, et al.
Diabetes Care|July 1, 1997
Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot StudyA I Adler, E J Boyko, J H Ahroni, et al.
The FEBS Journal|April 25, 2022
Dietary restriction and lifespan: adaptive reallocation or somatic sacrifice?Matthew D W Piper, Brooke Zanco, Carla M Sgrò, et al.
International Journal of Circumpolar Health|March 27, 1999
Glucose tolerance and insulin-resistance syndrome among St. Lawrence Island EskimosC D Schraer, S O Ebbesson, A I Adler, et al.
Diabetes Care|December 25, 2003
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66Richard J Stevens, Ruth L Coleman, Amanda I Adler, et al.
Diabetes Care|April 30, 2002
UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetesAmanda I Adler, Richard J Stevens, Andrew Neil, et al.
Kidney International|December 11, 2002
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)Amanda I Adler, Richard J Stevens, Sue E Manley, et al.
Eclinicalmedicine|January 7, 2025
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort studyRiccardo De Giorgi, Ivan Koychev, Amanda I Adler, et al.
Diabetologia|June 1, 2006
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)I M Stratton, C A Cull, A I Adler, et al.
Pageof 21